Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response.

Graham HT, Rotroff DM, Marvel SW, Buse JB, Havener TM, Wilson AG, Wagner MJ, Motsinger-Reif AA; ACCORD/ACCORDion Investigators..

Front Genet. 2016 Aug 17;7:138.

2.

Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.

Espeland MA, Probstfield J, Hire D, Redmon JB, Evans GW, Coday M, Lewis CE, Johnson KC, Wilmoth S, Bahnson J, Dulin MF, Green JB, Knowler WC, Kitabchi A, Murillo AL, Osei K, Rehman SU, Cushman WC; Look AHEAD Research Group.; ACCORD Study Group..

Am J Hypertens. 2015 Aug;28(8):995-1009. doi: 10.1093/ajh/hpu292.

3.

Antibiotic resistance-the need for global solutions.

Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O.

Lancet Infect Dis. 2013 Dec;13(12):1057-98. doi: 10.1016/S1473-3099(13)70318-9. Erratum in: Lancet Infect Dis. 2014 Mar;14(3):182. Lancet Infect Dis. 2014 Jan;14(1):11.

PMID:
24252483
4.

Determinants of weight gain in the action to control cardiovascular risk in diabetes trial.

Fonseca V, McDuffie R, Calles J, Cohen RM, Feeney P, Feinglos M, Gerstein HC, Ismail-Beigi F, Morgan TM, Pop-Busui R, Riddle MC; ACCORD Study Group..

Diabetes Care. 2013 Aug;36(8):2162-8. doi: 10.2337/dc12-1391.

5.

Surrogates and extra-familial interests.

Baergen R, Woodhouse W.

J Clin Ethics. 2013 Winter;24(4):332-7.

PMID:
24597420
6.

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

ACCORD Study Group., Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT.

N Engl J Med. 2011 Mar 3;364(9):818-28. doi: 10.1056/NEJMoa1006524.

7.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group..

Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Erratum in: Lancet. 2010 Oct 30;376(9751):1466.

8.

Effects of medical therapies on retinopathy progression in type 2 diabetes.

ACCORD Study Group.; ACCORD Eye Study Group., Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ.

N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Erratum in: N Engl J Med. 2011 Jan 13;364(2):190. N Engl J Med. 2012 Dec 20;367(25):2458.

9.

Effects of combination lipid therapy in type 2 diabetes mellitus.

ACCORD Study Group., Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP.

N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Erratum in: N Engl J Med. 2010 May 6;362(18):1748.

10.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

ACCORD Study Group., Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F.

N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286.

11.

Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials.

Mount DL, Feeney P, Fabricatore AN, Coday M, Bahnson J, Byington R, Phelan S, Wilmoth S, Knowler WC, Hramiak I, Osei K, Sweeney ME, Espeland MA; Look AHEAD and ACCORD Research Groups..

Clin Trials. 2009 Oct;6(5):416-29. doi: 10.1177/1740774509344440.

12.

Effects of intensive glucose lowering in type 2 diabetes.

Action to Control Cardiovascular Risk in Diabetes Study Group., Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT.

N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743.

13.

The development of a new day treatment program for older children (8-11 years) with behavioural problems: the GoZone.

McCarthy G, Baker S, Betts K, Bernard D, Dove J, Elliot M, Schneider N, Woodhouse W.

Clin Child Psychol Psychiatry. 2006 Jan;11(1):156-66.

PMID:
17087492
14.

A piece of my mind. Easy love.

Woodhouse WM.

JAMA. 2006 Jul 26;296(4):372. No abstract available.

PMID:
16868283
15.

Head circumference in autism and other pervasive developmental disorders.

Woodhouse W, Bailey A, Rutter M, Bolton P, Baird G, Le Couteur A.

J Child Psychol Psychiatry. 1996 Sep;37(6):665-71.

PMID:
8894947
16.

The association between triple X and psychosis.

Woodhouse WJ, Holland AJ, McLean G, Reveley AM.

Br J Psychiatry. 1992 Apr;160:554-7.

PMID:
1571760
17.

Complications of pregnancy and delivery and psychosis in adult life.

Kerwin R, Woodhouse W.

BMJ. 1991 Jul 20;303(6795):188. No abstract available.

18.

Housing in the tropics: some design problems.

Woodhouse WM.

R Soc Health J. 1966 Nov-Dec;86(6):341-6. No abstract available.

PMID:
5979587
19.

Complications of the impacted lower third molar.

WOODHOUSE WB.

Aust Dent J. 1948 May;52(3):179. No abstract available.

PMID:
18869458

Supplemental Content

Loading ...
Support Center